Работы, цитирующие эту работу

Работ: 3

Работа: Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

1. Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives

   Muqadas Shahzadi, Hamad Rafique, Ahmad Waheed +4

   Обзорная статьяCAR-T cell therapy researchTherapeutic Advances in Vaccines and Immunotherapy2024Цитирований: 1

   ABIABI:AkademIndex/openalex/2024.review-article.000014

2. Morphological and immunohistochemical characteristics of the molecular subtypes of urothelial carcinomas

   Y. I. Osmanov, Ж А Гаибов, Е А Коган +2

   СтатьяBladder and Urothelial Cancer TreatmentsRussian Journal of Archive of Pathology2019Цитирований: 0

   ABIABI:AkademIndex/openalex/2019.article.000877

3. DERN CONTROL POINT INHIBITORS AND THEIR POSSIBILITIES FOR THE THERAPY OF METASTATIC UROTELIAL CANCER

   M.N. Tillyashajhov, С В Камышов, E. P. Bojko

   СтатьяBladder and Urothelial Cancer TreatmentsEurasianUnionofScientists2020Цитирований: 0

   ABIABI:AkademIndex/openalex/2020.article.002791